United Therapeutics Corporation (UTHR) has a MoatMap StockRank of 98/100 based on Quality (85/100), Value (36/100), and Momentum (69/100) factor scores. The current signal is STRONG BUY. United Therapeutics, a specialty pharmaceutical company focused on rare diseases, aligns perfectly with the 'Specialty Pharma & Biotech Growth' theme. Its exceptionally high quality score (Q:83) points to strong intellectual property, pricing power, and a durable moat, making it a compelling quality compounder. The market, distracted by broader macro uncertainties, is likely underestimating the consistent demand and defensible growth in this sector, creating an asymmetric opportunity in a defensive growth play.